GW
CNST

GW & Wade’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

GW & Wade’s Portfolio CNST Stock Details CNST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-12,262
Closed -$79K – 250
2019
Q3 		$79K Hold
12,262
– – 0.01% 233
2019
Q2 		$151K Hold
12,262
– – 0.01% 229
2019
Q1 		$166K Buy
+12,262
New +$110K 0.02% 222

Other funds holding CNST

PS
Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
TG
TRV GP Boston, Massachusetts $18.9M AUM 541.67% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
VMI
VHCP Management III New York $504M AUM 683.12% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ROTUOC
Regents of the University of California Oakland, California $3.01B AUM 11.91% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VMI
VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return

GW & Wade's CNST Position: Q4 2019 in Review

GW & Wade sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q4 2019, closing a stake of 12,262 shares — an estimated $79K sold.

GW & Wade first reported a position in CNST in Q1 2019 and held it in 3 quarters. The position peaked at $166K in Q1 2019. 100 funds tracked by Wall St. Rank hold CNST as of Q4 2019.

  • GW & Wade reported no remaining Constellation Pharmaceuticals, Inc. position as of Q4 2019 after selling out during the quarter.
  • GW & Wade sold 12,262 Constellation Pharmaceuticals, Inc. shares in Q4 2019, an estimated $79K.
  • GW & Wade first reported a position in Constellation Pharmaceuticals, Inc. in Q1 2019 and held it in 3 quarters.
  • GW & Wade's Constellation Pharmaceuticals, Inc. position peaked at $166K in Q1 2019.
  • 100 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q4 2019.

Based on GW & Wade's 13F filing for Q4 2019, filed 7 Feb 2020.